IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes

The epidemics of metabolic disease, in the form of obesity and type 2 diabetes, are a growing public health concern. However, incretin-based therapeutics have transformed our ability to address these diseases. While this current generation of incretin analogues show weight regain upon cessation of t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Andrew J. Elmendorf, Mostafa Yousefian, Il-Man Kim, J. Andrew Hardaway, Kirk Habegger, Jonathan N. Flak
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-01-01
coleção:	Pharmacological Research
Assuntos:	GLP1-R GIPR GCGR Body weight Energy expenditure
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S104366182500502X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!